Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Oriental Biotech is a leading Chinese biotech specializing in innovative biologic drugs—especially monoclonal/bispecific antibodies and fusion proteins—for oncology, metabolic disease (notably diabetes), autoimmune disorders, and more. The company has over twenty active R&D programs with several late-stage or approved assets including biosimilars. It also operates significant manufacturing facilities certified to international standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Oriental Biotechnology.